Breast Cancer Clinical Trial

Analysis of Surgery in Patients Presenting With Stage IV Breast Cancer

Summary

The purpose of this study is to study patients presenting with stage IV breast cancer. Stage IV means that the breast cancer has spread to another part of the body outside the breast. This study is important because in different parts of the country some patients are being offered surgical treatment for the breast tumor and some are not. The doctors do not know if surgery for the breast tumor is helpful in patients with stage IV breast cancer. The doctors will collect information about the patient and their treatment to learn more about how patients and doctors make treatment decisions. The doctor will also collect blood samples and tissue samples for laboratory studies to learn more about tumors that have spread to other parts of the body.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

Age 18 years or older
Known or suspected Stage IV breast cancer with intact primary tumor
Known or suspected Stage IV breast cancer with intact primary tumor, having begun systemic therapy within the past 12 months
Known or suspected Stage IV breast cancer within 3 months of local breast surgery
Known or suspected Stage IV breast cancer within 3 months of local breast surgery, having begun systemic therapy within the past 12 months

Exclusion Criteria:

Primary breast cancer diagnosis made by FNA only and no pre-treatment core biopsy planned for diagnostic or research purposes.
Failure of MSKCC or participating site to confirm Stage IV breast cancer diagnosis by biopsy within 30 days of study enrollment

Study is for people with:

Breast Cancer

Estimated Enrollment:

100

Study ID:

NCT00941759

Recruitment Status:

Active, not recruiting

Sponsor:

Memorial Sloan Kettering Cancer Center

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There are 13 Locations for this study

See Locations Near You

University of Alabama at Birmingham
Birmingham Alabama, 35294, United States
University of California San Francisco
San Francisco California, 94143, United States
Georgetown University
Washington District of Columbia, , United States
Washington Cancer Institute at Washington
Washington District of Columbia, , United States
University of Chicago
Chicago Illinois, , United States
The Indiana University Simon Cancer Center
Indianapolis Indiana, , United States
John Hopkins Medical Center
Baltimore Maryland, 21287, United States
Dana Farber Cancer Institute
Boston Massachusetts, 02115, United States
University of Michigan Health System
Ann Arbor Michigan, 48109, United States
Mayo Clinic
Rochester Minnesota, 55905, United States
Memoral Sloan Kettering Cancer Center
Basking Ridge New Jersey, , United States
Memorial Sloan Kettering Commack
Commack New York, 11725, United States
Memorial Sloan Kettering Cancer Center
New York New York, 10065, United States
Memorial Sloan Kettering Rockville Centre
Rockville Centre New York, 11570, United States
Memorial Sloan Kettering Nassau
Uniondale New York, 11553, United States
University of North Carolina School of Medicine
Chapel Hill North Carolina, 27514, United States
Duke University
Durham North Carolina, , United States
University of Pittsburgh Medical Center
Pittsburgh Pennsylvania, , United States
Vanderbilt-Ingram Cancer Center
Nashville Tennessee, 37232, United States
Md Anderson Cancer Center
Houston Texas, 77030, United States

How clear is this clinincal trial information?

Study is for people with:

Breast Cancer

Estimated Enrollment:

100

Study ID:

NCT00941759

Recruitment Status:

Active, not recruiting

Sponsor:


Memorial Sloan Kettering Cancer Center

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.